Keyword: Ian Read

News

Pfizer and Allergan Bury Merger Plans

07.04.2016 - The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...

News

Pfizer to Buy Allergan for $160 Billion

24.11.2015 - Confirming rumors of the past weekend, US pharmaceutical giant Pfizer has said it will buy drugmaker Allergan for $160 million and move its headquarters to Ireland. The ever faster...

News

Pfizer and Allergan in Merger Talks

30.10.2015 - US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...

Markets & Companies

Pharma Players Mostly Lift 2015 Guidance

07.10.2015 - After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...

Markets & Companies

Drugs Industry Battered by Currency and Competition

13.03.2015 - Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...

Strategy & Management

International Drugmakers Meet Challenges

08.05.2014 - In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...

News

Pfizer on Lookout for Mid-size Drug Deals

02.05.2012 - Pfizer, which last week agreed to sell its baby formula business for almost $12 billion, is on the hunt for companies with promising new treatments for diabetes, cancer and...

News

Chasing Cheaper Cancer Drugs

02.04.2012 - In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research...